ITRM930365A0 - Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee. - Google Patents

Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Info

Publication number
ITRM930365A0
ITRM930365A0 IT93RM365A ITRM930365A ITRM930365A0 IT RM930365 A0 ITRM930365 A0 IT RM930365A0 IT 93RM365 A IT93RM365 A IT 93RM365A IT RM930365 A ITRM930365 A IT RM930365A IT RM930365 A0 ITRM930365 A0 IT RM930365A0
Authority
IT
Italy
Prior art keywords
carnitine
hex
esters
treatment
pharmaceutical compositions
Prior art date
Application number
IT93RM365A
Other languages
English (en)
Inventor
Claudio Cavazza
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Publication of ITRM930365A0 publication Critical patent/ITRM930365A0/it
Priority to ITRM930365A priority Critical patent/IT1261696B/it
Priority to ES94108016T priority patent/ES2126674T3/es
Priority to AT94108016T priority patent/ATE174216T1/de
Priority to DE69415081T priority patent/DE69415081T2/de
Priority to EP94108016A priority patent/EP0628308B1/en
Priority to DK94108016T priority patent/DK0628308T3/da
Priority to CA002124748A priority patent/CA2124748A1/en
Priority to ZA943808A priority patent/ZA943808B/xx
Priority to KR1019940012266A priority patent/KR950000141A/ko
Priority to US08/253,051 priority patent/US5639767A/en
Priority to JP6121068A priority patent/JPH07309820A/ja
Publication of ITRM930365A1 publication Critical patent/ITRM930365A1/it
Application granted granted Critical
Publication of IT1261696B publication Critical patent/IT1261696B/it
Priority to GR990400631T priority patent/GR3029536T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
ITRM930365A 1993-06-02 1993-06-02 Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee. IT1261696B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM930365A IT1261696B (it) 1993-06-02 1993-06-02 Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ES94108016T ES2126674T3 (es) 1993-06-02 1994-05-25 Empleo de o-esteres de l-carnitina con acidos aromaticos para el tratamiento de dermatosis.
AT94108016T ATE174216T1 (de) 1993-06-02 1994-05-25 Verwendung von l-carnitin-o-estern mit aromatischen säuren zur behandlung der dermatosen
DE69415081T DE69415081T2 (de) 1993-06-02 1994-05-25 Verwendung von L-Carnitin-O-Estern mit aromatischen Säuren zur Behandlung der Dermatosen
EP94108016A EP0628308B1 (en) 1993-06-02 1994-05-25 Use of O-esters of L-carnitine with aromatic acids for the treatment of dermatoses
DK94108016T DK0628308T3 (da) 1993-06-02 1994-05-25 Anvendelse af O-estere af L-carnitin med aromatiske syrer til behandling af dermatoser
CA002124748A CA2124748A1 (en) 1993-06-02 1994-05-31 Use of o-esters of l-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses
ZA943808A ZA943808B (en) 1993-06-02 1994-06-01 Use of O-esters of L-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses
KR1019940012266A KR950000141A (ko) 1993-06-02 1994-06-01 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도
US08/253,051 US5639767A (en) 1993-06-02 1994-06-02 Therapeutical method for treating dermatoses based on the use of O-esters of L-carnitine with aromatic acids
JP6121068A JPH07309820A (ja) 1993-06-02 1994-06-02 Ｌ−カルニチンの芳香族酸とのｏ−エステル類を含む皮膚病処置のための医薬組成物
GR990400631T GR3029536T3 (en) 1993-06-02 1999-03-01 Use of O-esters of L-carnitine with aromatic acids for the treatment of dermatoses.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930365A IT1261696B (it) 1993-06-02 1993-06-02 Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Publications (3)

Publication Number Publication Date
ITRM930365A0 true ITRM930365A0 (it) 1993-06-02
ITRM930365A1 ITRM930365A1 (it) 1994-12-02
IT1261696B IT1261696B (it) 1996-05-29

Family

ID=11401791

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930365A IT1261696B (it) 1993-06-02 1993-06-02 Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Country Status (12)

Country Link
US (1) US5639767A (it)
EP (1) EP0628308B1 (it)
JP (1) JPH07309820A (it)
KR (1) KR950000141A (it)
AT (1) ATE174216T1 (it)
CA (1) CA2124748A1 (it)
DE (1) DE69415081T2 (it)
DK (1) DK0628308T3 (it)
ES (1) ES2126674T3 (it)
GR (1) GR3029536T3 (it)
IT (1) IT1261696B (it)
ZA (1) ZA943808B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
EP0951909B2 (en) 1998-03-19 2010-10-20 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition comprising a L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and/or constituent thereof
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10133200A1 (de) 2001-07-07 2003-01-23 Beiersdorf Ag Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
ITRM20020055A1 (it) * 2002-02-04 2003-08-04 Aldo Fassi Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti
KR100783145B1 (ko) * 2002-04-23 2007-12-07 삼성광주전자 주식회사 선회형 흡입구를 가지는 청소 로봇
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
CN107540605B (zh) * 2016-12-28 2020-03-06 宁波见睿新材料有限公司 用于头发或头皮护理的胆碱酯类化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2354769A1 (fr) * 1976-06-15 1978-01-13 Tanabe Seiyaku Co Derives de nicotinoylcarnitines, leur preparation et leurs utilisations therapeutiques
CH679856A5 (it) * 1990-07-04 1992-04-30 Lonza Ag

Also Published As

Publication number Publication date
US5639767A (en) 1997-06-17
ATE174216T1 (de) 1998-12-15
JPH07309820A (ja) 1995-11-28
CA2124748A1 (en) 1994-12-03
ZA943808B (en) 1995-01-30
EP0628308A1 (en) 1994-12-14
DK0628308T3 (da) 1999-08-16
KR950000141A (ko) 1995-01-03
ES2126674T3 (es) 1999-04-01
EP0628308B1 (en) 1998-12-09
IT1261696B (it) 1996-05-29
DE69415081T2 (de) 1999-04-29
ITRM930365A1 (it) 1994-12-02
GR3029536T3 (en) 1999-06-30
DE69415081D1 (de) 1999-01-21

Similar Documents

Publication Publication Date Title
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITRM930399A0 (it) Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITRM920761A0 (it) Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
ITTO920880A0 (it) Procedimento per la preparazione di acidi carbossilici o loro esteri mediante scissione ossidativa di acidi grassi insaturi o loro esteri.
ITRM930365A0 (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
ITRM910327A0 (it) Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie.
IT8748221A0 (it) Procedimento di preparazione di esteri di acidi carbossilici insaturi
IT1234230B (it) Solfonammidi di benzilidene canfora derivanti da amminoacidi e loro impiego in cosmesi particolarmente come filtri solari
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
FI942581A (fi) Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi
ITPD910163A0 (it) Nuovo uso di esteri di polisaccarici acidi
IT8720438A0 (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche.
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
CA2075926A1 (en) Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them
IT1216806B (it) Esteri di acidi alchilpoliossialchi lencarbossilici, loropreparazione eloro impiego come tensioattivi
NO911892D0 (no) Fremgangsmaate for fremstilling og anvendelse som medikamenter av alfa-oksopyrrol(2,3-b)indoleddiksyrer, estere, amider og beslektede analoger.
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
IT1227158B (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
IT1197888B (it) Procedimento per la preparazione di esteri carbossilici insaturi
FR2733981B1 (fr) Procede de preparation des esters d'acides hydroxybenzoiques
ITMI921715A0 (it) Procedimento per la preparazione di acidi alogenobenzoici
IT8019879A0 (it) Processo per la loro preparazione, esteri di acidi arilpropionici ad e composizioni farmaceutiche attivita' antiinfiammatoria, relative.
IT8222460A0 (it) Esteri 2-metossi-fenilici di acidi 2', 4'-difluoro-4-idrossi-aperta parentesi quadra 1, 1'-bifenilchiusa parentesi quadra-3-carbossilici ad attivita'antiinfiammatoria e balsamica, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970517